News

We are strongly committed
to delivering insulin to our patients

Życie bez cukrzycy – czy można zapobiec rozwojowi choroby?

A life without diabetes – can the disease be prevented?

Ongoing research is happening to understand factors that could influence the destruction of insulin producing cells in type 1 diabetes. However, for type 2 (...)

Coronavirus and diabetes
– guidelines for patients
with diabetes

In the past weeks we have all been asking ourselves whether or not we are in the risk group more vulnerable to COVID-19 and (...)

Coronavirus – safety measures applied at BIOTON S.A.

Our company operates in the very important area of healthcare, which is why we treat safety very seriously. As a result of the worrisome (...)

The future of treating diabetes – report from the 14th “What’s New in Diabetes” conference

What is the future of treating diabetes? What new solutions are available in term of therapy? How to avoid hypoglycaemia in insulin-treated patients? These (...)

22 January 2020

Bioton partnerem Medycyna Trzech Tenorów

MEDICINE OF THE THREE TENORS – SCIENTIFIC AND TRAINING SYMPOSIA WITH THE PARTICIPATION OF BIOTON S.A

The first part of the series of scientific and training symposia "Medicine of the Three Tenors 2019 - practice more difficult than guidelines" has (...)

Bioton prezentuje GensuPen2 na konferencji w San Francisco

BIOTON S.A. PRESENTS THE RESULTS OF THE GENSUPEN2 RESEARCH PROGRAMME AT A CONFERENCE IN SAN FRANCISCO

The American Diabetes Association (ADA) is the organiser of the largest scientific meeting on diabetes in the world. This year, the 79th edition of (...)